Screener
Aura Biosciences, Inc. AURA Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total other income | 1,192 | 1,570 |
| Loss before income taxes | (33,674) | (27,465) |
| Income tax provision, net | (11) | (18) |
| Net loss | $(33,685) | $(27,483) |
| Net loss per common share—basic and diluted | $(0.50) | $(0.55) |
| Weighted average common stock outstanding—basic and diluted | 67,447,576 | 50,126,148 |
| Comprehensive loss: | ||
| Net loss | $(33,685) | $(27,483) |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s net income?
- Aura Biosciences, Inc. (AURA) reported net income of -$33.69M in Q1 2026.
- How has Aura Biosciences, Inc.'s net income changed year-over-year?
- Aura Biosciences, Inc.'s net income decreased by 22.6% year-over-year, from -$27.48M to -$33.69M.
- What is the long-term trend for Aura Biosciences, Inc.'s net income?
- Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s net income has grown at a 31.7% compound annual growth rate (CAGR), from -$35.25M to -$106.19M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Aura Biosciences, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude